News Detail
JAIPUR, 7 NOV 2022: Low-dose immunotherapy, a new modality in cancer treatment, could be a game-changer if it shows satisfactory results.
City’s oncologists have begun treating the patients in advance stage of head and neck cancer and they are closely monitori......
View Details
Source : The Times of India
Low-dose immunotherapy
TATA Group
jaipur
hemant malhotra
dr tarachand gupta
cancer treatment
advanced-stage lung
bladder
liver
kidney
melanoma (skin cancer)
lymphoma cancers
Related News
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)
- One-third of older people and individuals admitted to the hospital experienced ADRs: Study (17-11-2024)
- Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII–biointerface binding (13-11-2024)
- IISc scientists develop enzyme-based solution to break antibiotic-resistant biofilms (13-11-2024)
- Japan performs world's first stem cell-treatment to restore vision (12-11-2024)
- Scientist treated her own cancer with viruses she grew in the lab (12-11-2024)
- Innovative use of silk in medical devices (10-11-2024)
- Three-fold throughput nitrosamine analysis in drug products using SIFT-MS (07-11-2024)